Biorestorative Therapies Share Price Today
(NASDAQ: BRTX)

Name: Biorestorative Therapies Share Price Today (NASDAQ: BRTX) - Biorestorative Therapies Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Biorestorative Therapies share price is $2.38 & ₹207.29 as on 5 Feb 2025, 2.30 'hrs' IST

$2.38

▲

0.02

(0.85%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Biorestorative Therapies share price in Dollar and Rupees. Guide to invest in Biorestorative Therapies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Biorestorative Therapies, along with analyst recommendations, forecasts, and comprehensive financials.

Biorestorative Therapies share price movements

Today's Low: $2.27
Today's High: $2.44
$2.38
4.62%
Downside
Day's Volatility :6.9%
Upside
2.39%
52 Weeks Low: $1.03
52 Weeks High: $3.67
$2.38
56.72%
Downside
52 Weeks Volatility :71.93%
Upside
35.15%

Biorestorative Therapies (BRTX) Returns

Period	Biorestorative Therapies Inc	Index (Russel 2000)
3 Months	43.03%	0.0%
6 Months	78.79%	0.0%
1 Year	50.32%	0.0%
3 Years	-38.86%	-11.7%

Biorestorative Therapies (BRTX) Key Statistics

in dollars & INR

Previous Close	$2.36
Open	$2.31
Today's High	$2.4383
Today's Low	$2.27
Market Capitalization	$16.3M
Today's Volume	$66.0K
52 Week High	$3.6699
52 Week Low	$1.03
Revenue TTM	$377.0K
EBITDA	$-11.9M
Earnings Per Share (EPS)	$-2.38
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.12%

How to invest in Biorestorative Therapies Stock (BRTX) from India?

It is very easy for Indian residents to invest directly in Biorestorative Therapies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biorestorative Therapies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biorestorative Therapies or BRTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biorestorative Therapies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biorestorative Therapies shares which would translate to 0.366 fractional shares of Biorestorative Therapies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biorestorative Therapies, in just a few clicks!

Returns in Biorestorative Therapies (BRTX) for Indian investors in Rupees

The Biorestorative Therapies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Biorestorative Therapies investment value today

Current value as on today

₹1,56,457

Returns

₹56,457

(+56.46%)

Returns from Biorestorative Therapies Stock

₹51,592 (+51.59%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Biorestorative Therapies (BRTX)

-43%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Biorestorative Therapies Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Biorestorative Therapies

Geode Capital Management, LLC
0.81%
StoneX Group Inc
0.72%
Wealth Alliance, LLC
0.58%
Vanguard Group Inc
0.30%
State Street Corp
0.30%
Renaissance Technologies Corp
0.29%

Analyst Recommendation on Biorestorative Therapies

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Biorestorative Therapies(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biorestorative Therapies Stock (BRTX)

What analysts predicted

Upside of 446.22%

Target:

$13.00

Current:

$2.38

Insights on Biorestorative Therapies Stock (Ticker Symbol: BRTX)

Price Movement
In the last 1 month, BRTX stock has moved up by 57.3%
Increasing Revenue
Revenue is up for the last 4 quarters, 30.7K → 233.6K (in $), with an average increase of 45.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -4.02M → -1.09M (in $), with an average increase of 269.1% per quarter
BRTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 74.3%
BRTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 129.5%
Price to Sales
ForBRTX every $1 of sales, investors are willing to pay $42.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

BRTX Biorestorative Therapies Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$130.0K	↑ 17.12%
Net Income	$-14.6M	↑ 17.02%
Net Profit Margin	-11.3K%	↑ 9.69%

	FY20	Y/Y Change
Revenue	$77.0K	↓ 40.77%
Net Income	$-12.3M	↓ 16.34%
Net Profit Margin	-15.9K%	↓ 4647.56%

	FY21	Y/Y Change
Revenue	$46.0K	↓ 40.26%
Net Income	$-29.9M	↑ 144.3%
Net Profit Margin	-65.1K%	↓ 49168.75%

	FY22	Y/Y Change
Revenue	$119.8K	↑ 160.43%
Net Income	$-18.0M	↓ 39.83%
Net Profit Margin	-15.0K%	↑ 50045.93%

	FY23	Y/Y Change
Revenue	$145.8K	↑ 21.7%
Net Income	$-10.4M	↓ 42.17%
Net Profit Margin	-7.1K%	↑ 7892.79%

	FY24	Y/Y Change
Revenue	$145.8K	↑ 0.0%
Net Income	$-10.4M	↑ 0.0%
Net Profit Margin	-7.1K%	↑ 0.0%

	Q1 FY23	Q/Q Change
Revenue	$31.3K	↑ 745.95%
Net Income	$-5.6M	↑ 46.71%
Net Profit Margin	-17.9K%	↑ 85386.42%

	Q2 FY23	Q/Q Change
Revenue	$64.5K	↑ 106.07%
Net Income	$-3.0M	↓ 46.85%
Net Profit Margin	-4.6K%	↑ 13294.52%

	Q3 FY23	Q/Q Change
Revenue	$30.7K	↓ 52.4%
Net Income	$-83.3K	↓ 97.2%
Net Profit Margin	-271.44%	↑ 4349.57%

	Q1 FY24	Q/Q Change
Revenue	$35.0K	↑ 14.01%
Net Income	$-2.2M	↑ 2567.92%
Net Profit Margin	-6.4K%	↓ 6080.72%

	Q2 FY24	Q/Q Change
Revenue	$89.1K	↑ 154.57%
Net Income	$-4.0M	↑ 81.2%
Net Profit Margin	-4.5K%	↑ 1830.77%

	Q3 FY24	Q/Q Change
Revenue	$233.6K	↑ 162.18%
Net Income	$-1.1M	↓ 72.91%
Net Profit Margin	-467.22%	↑ 4054.17%

	FY20	Y/Y Change
Profit	$77.0K	-

	FY21	Y/Y Change
Profit	$-159.2K	↓ 306.76%

	FY22	Y/Y Change
Profit	$-160.9K	↑ 1.04%

	FY23	Y/Y Change
Profit	$-19.9K	↓ 87.61%

	FY24	Y/Y Change
Profit	$145.8K	↓ 831.38%

	Q1 FY23	Q/Q Change
Profit	$-37.1K	↓ 63.37%

	Q2 FY23	Q/Q Change
Profit	$-6.0K	↓ 83.71%

	Q3 FY23	Q/Q Change
Profit	$-11.4K	↑ 89.58%

	Q1 FY24	Q/Q Change
Profit	$-7.7K	↓ 32.61%

	Q2 FY24	Q/Q Change
Profit	$82.6K	↓ 1171.05%

	Q3 FY24	Q/Q Change
Profit	$215.4K	↑ 160.69%

	FY19	Y/Y Change
Operating Cash Flow	$-6.9M	↑ 35.54%
Investing Cash Flow	$-35.6K	↑ 176.87%
Financing Cash Flow	$6.8M	↑ 42.97%

	FY20	Y/Y Change
Operating Cash Flow	$-2.0M	↓ 71.61%
Investing Cash Flow	$-35.6K	↑ 0.0%
Financing Cash Flow	$5.0M	↓ 26.49%

	FY21	Y/Y Change
Operating Cash Flow	$-3.3M	↑ 69.52%
Investing Cash Flow	$-30.7K	↓ 13.96%
Financing Cash Flow	$21.3M	↑ 324.15%

	FY22	Y/Y Change
Operating Cash Flow	$-5.9M	↑ 76.3%
Investing Cash Flow	$-13.5M	↑ 43866.95%
Financing Cash Flow	$21.1M	↓ 1.17%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-2.3M	↑ 49.28%
Investing Cash Flow	$665.8K	↓ 120.04%
Financing Cash Flow	$411.7K	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.1M	↓ 51.88%
Investing Cash Flow	$665.8K	↑ 0.0%
Financing Cash Flow	$411.7K	↑ 0.0%

Biorestorative Therapies Technicals Summary

Sell

Neutral

Buy

Biorestorative Therapies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Biorestorative Therapies (BRTX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biorestorative Therapies Inc	48.43%	78.79%	50.32%	-38.86%	-66.38%
Biontech Se	-0.32%	51.19%	24.81%	-30.66%	288.02%
Regeneron Pharmaceuticals, Inc.	-6.9%	-37.55%	-28.89%	7.15%	74.63%
Vertex Pharmaceuticals Incorporated	16.87%	0.96%	13.03%	93.36%	95.94%
Alnylam Pharmaceuticals, Inc.	17.76%	5.53%	59.46%	84.7%	118.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biorestorative Therapies Inc	NA	NA	0.0	0.0	-0.17	-0.53	NA	1.44
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.64	16.64	1.08	44.92	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biorestorative Therapies Inc	Buy	$16.3M	-66.38%	NA	0.0%
Biontech Se	Buy	$29.7B	288.02%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$74.0B	74.63%	16.64	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$118.9B	95.94%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.0B	118.8%	NA	-15.86%

About Biorestorative Therapies

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs relate to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is based in Melville, New York.

Organization	Biorestorative Therapies
Employees	11
CEO	Mr. Lance Alstodt
Industry	Biotechnology

Management People of Biorestorative Therapies

Name	Title
Mr. Lance Alstodt	Chairman of the Board, President & CEO
Mr. Robert Eugene Kristal	Chief Financial Officer
Mr. Francisco J. Silva	Chief Scientist, VP of Research & Development, Secretary and Director
Stephen Kilmer	Investor Relations Officer
Dr. Wayne J. Olan M.D.	Clinical Director of Regenerative Disc & Spine Program and Member of Scientific Advisory Board

Important FAQs about investing in BRTX Stock from India :

What is Biorestorative Therapies share price today?

Biorestorative Therapies share price today stands at $2.38, Open: $2.31 ; Previous Close: $2.36 ; High: $2.44 ; Low: $2.27 ; 52 Week High: $3.67 ; 52 Week Low: $1.03.

The stock opens at $2.31, after a previous close of $2.36. The stock reached a daily high of $2.44 and a low of $2.27, with a 52-week high of $3.67 and a 52-week low of $1.03.

Can Indians buy Biorestorative Therapies shares?

Yes, Indians can invest in the Biorestorative Therapies (BRTX) from India.

With INDmoney, you can buy Biorestorative Therapies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biorestorative Therapies at zero transaction cost.

How can I buy Biorestorative Therapies shares from India?

It is very easy to buy Biorestorative Therapies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biorestorative Therapies (BRTX) be purchased?

Yes, you can buy fractional shares of Biorestorative Therapies with INDmoney app.

What are the documents required to start investing in Biorestorative Therapies stocks?

To start investing in Biorestorative Therapies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.